Erebouni Medical Center
Medical Journal Erebouni

Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris. A 6-week randomised do


Report

DATE – 2008 -2012
Name of the specialist – Hayrapetyan G.G.
Role – Principal Investigator
(study protocol N CL3 16257 068). S-16257-2-IVABRADINE Short code title: CL3 -16257 -PO-C  - PLACEBO-1240 P-STABLE effort angina/ Calcium antagonist”
-    International Multicenter double – blind placebo-controlled research SIGNIFY (research protocol N CL3 16257 068)

Jointly participating Organization – Servier Laboratories (France) (Gagik Velijanyan, www.servier.com/)
Result – effectiveness of ivabradine during the stable stenocardia is proved
Publications – see in the list of scientific publications

In accordance with the "Law of Copyright and Related Rights" when copying or reproduction of materials posted on this site, specify the source - the Web site of the Erebouni Medical Center - erebunimed.com is highly requested.
Back to top